The potential for generic and cheaper semaglutide for wide use in the treatment of obesity, diabetes, and a range of other conditions is so mind-boggingly large, we think the time is ripe for many governments to start to plan for how to maximise their potential
It was originally made as a drug to help treat certain skin conditions
Nadkarni, P., Chepurny, O
A patient might be cautious of increasing semaglutide from 0.25 to 0.5 mg, so we might discuss microdosing to achieve a dose in between, says Tchang
7 This limits capacity for surveillance, monitoring uptake, best-practice use, and real-world evidence on safety and effectiveness